The Health Planning Commission revealed the focus of medical reform: basic medicine, Chinese medicine or face adjustment
On June 29, the National Health and Family Planning Commission announced that the Department of Medicine and Administration launched 30 projects commissioned in 2015. Public information indicates that the main responsibility of the Pharmacy Division is to set a national drug policy. In the explanation of the entrusted research topic, the Pharmacy Department should make clear that these 30 topics are mainly for the preparation of the top design of the medical reform.
In the press release, the Pharmacy Secretary stated that:
In 2015, in accordance with the overall deployment requirements of the medical reform, the Pharmacy Department focused on the difficulties in medical reform, work priorities and social hotspots, strengthened research on key issues of drug policy, identified 30 research topics, and entrusted domestic universities, research institutes, relevant administrative departments and related associations. A total of 40 units carried out research work in order to provide reference for the formulation of policy measures, scientific decision-making, and improvement of top-level design. Research work is currently underway.
Studying the direction of the research project commissioned by the Health Planning Commission, we also come to the next step of the national medical reform and the trend of reform:
1. In terms of drug bidding, domestic brands may still have separate quality levels:
National Health and Family Planning Commission Statistical Information Center Research on the Safety and Development of Drug Centralized Purchasing Data
Saibailan Comments: Safety is secondary, development and utilization research is the main, the Statistical Information Center of the Health Planning Commission is the organization to build a national customs clearance platform, in accordance with the latest release of the State Council, the implementation of the new regulations of the State Council bidding procurement requirements of the No. 70 document At the end of this year, the drug bidding and procurement platforms of all provinces in the country must be networked with the national recruitment and management platform. The data collected will be unprecedentedly open, and the problems that drug companies are most worried about when the drug prices are open and streaked, the application of these bidding data The National Health and Family Planning Commission obviously wants to develop more. It is well known that after the collection of big data, its role is unlimited development.
Comparative Study on Comprehensive Evaluation System of Drug Quality in Tianjin Pharmaceutical Purchasing Center
Cypress Blue comment: After the drug price is released, the most uncomfortable thing is the brand medicine. In the past, there was the government's highest retail price pricing. In the bidding, many places were also included in the higher quality level. Now, after the drug price is released, There is no high price basis. In the double envelope bidding, the technical standard does not bring the business standard, and the price theory heroes force everyone to rush to do low-cost drugs. Now, a comprehensive evaluation of the comprehensive evaluation of drug quality is a good news for branded pharmaceutical companies, and there may still be a separate quality level.
Optimization and Comparative Study on the Purchasing Mode of Medical High-value Consumables at Home and Abroad
Cypress Blue Comments: The device has to be hacked like a drug. The era of profiteering has passed, and we are actively preparing for the tide of price cuts.
Peking University Medical Management International Research Center Research on the quantity procurement, recruitment and implementation methods and performance evaluation indicators in some areas
Cypress Blue Comments: There is only one hope, I hope the research institutions can tell the truth, and the investigation is objective and true.
Second, essential drugs: proprietary Chinese medicines, catalogue is the biggest concern
Analysis and Analysis of the Implementation of the Basic Drug System in China International Economic Exchange Center
Follow-up evaluation of the implementation of WHO's essential drug accessibility bill at West China Second Hospital of Sichuan University
Cypress Blue Comments: In 2009, the medical reform began to establish a basic drug system. Now it is re-evaluated, showing that the basic drug system is looking back. However, the possibility of abolishing the basic drug system is too small. The implementation of the basic drug system is the biggest problem. Not enough, so our catalog adjusts how to adjust.
Peking University People's Hospital, Shenyang Pharmaceutical University, a comprehensive evaluation of some essential drugs (partial vaccine, hepatitis B antiviral drugs)
Cypress Blue Comments: A class of vaccines, hepatitis B antiviral drug manufacturers focus on.
China Medical Industry Information Center, Shanghai Health and Family Planning Commission, Research on the Basic Guarantee Policy for the Basic Drugs of the Elderly
Cypress Blue Comments: Free often means the most efficient or best, such as free family planning supplies, many are wasted.
Analysis of the status quo and development trend of basic drug quality standards of the National Pharmacopoeia Commission and Guangzhou University of Traditional Chinese Medicine
Optimization of the Structure of Essential Drugs in China Pharmaceutical University and Beijing University of Chinese Medicine
Beijing Children's Hospital Comparative study of the WHO Children's Drug Catalogue and the National Essential Drugs List
Pilot study on comprehensive evaluation system for clinical use of children in Beijing Children's Hospital, West China Second Hospital of Sichuan University and Children's Hospital of Fudan University
Sichuan University Drug Policy Research Center, Xuanwu Hospital Essential drug pharmacology and evidence-based medical evaluation methods, database research (cardiovascular drugs)
Saibailan Comments: From the basis of the quality of the drug and the catalogue unit, the University of Chinese Medicine is the main entrusting party. Does it mean that the quality of essential medicines is the focus of Chinese medicine?
The topic of children's medicine shows that children's medicines are expected to expand, especially in essential medicines, children's medicines have achieved great development.
Among the subjects of cardiovascular drugs, chronic diseases account for a large proportion in the pharmaceutical market, and cardiovascular drugs are being evaluated in pharmacoeconomics and evidence-based medicine. These drugs have steadily strengthened research in these two areas. Some provinces and cities have started piloting chronic diseases and have developed access lists. Will it prove that they are more economical and useful in the future to enter the chronic disease catalogue? It is worthy of attention.
China Pharmaceutical Innovation Promotion Association
Cypress Blue Comments: The topic of common drug-equipped models in public hospitals has not revealed more content, but it must be concerned. The current mode of equipment is centralized drug procurement. Will this method change? This is a topic organized by the association. It is good news for pharmaceutical companies and hopes that their recommendations will be adopted.
Third, in terms of medical policy, there will be breakthroughs in medical separation and mobile medical care.
National Health and Family Planning Commission Health Development Research Center, comparative analysis of drug policy frameworks at home and abroad
Research on China National Economic Research Center of Peking University, Drug Supply Security System and National Governance System Construction in Pharmaceuticals
China Pharmaceutical University Drug Purchasing and Price, Medical Insurance, Circulation and Other Policy Relevance Studies
National School of Administration Research on National Drug Policy Coordination Mechanism
China Pharmaceutical University Research on Domestic Drug Policy Laws and Regulations
University of International Business and Economics, Renmin University of China TTP, TTIP analysis of China's drug research and development, production strategy
Peking University People's Hospital Outpatient Pharmacy, Retail Pharmacy, Internet Drug Purchase Mode Comparison and Pharmacist Online Service Model Research
Cypress Blue Comments: From the perspective of medical policy, the task is relatively high, learning foreign countries, laws and regulations, as well as coordination mechanisms and association research on the links between the three doctors. These topics should be consistent with the old-fashioned topic. A big highlight is the outpatient pharmacy, retail pharmacy, Internet drug purchase model and pharmacist online service model research, medical separation, Internet drug purchase and online diagnosis and treatment.
Fourth, rational use of drugs, licensed pharmacists to develop the future
Nanjing University of Traditional Chinese Medicine Basic Framework and Main Contents of the Pharmacist Law
Guizhou Provincial Health and Family Planning Commission Research on the management of pharmacy in primary health care institutions
Research on Pharmacy Reform in the Pilot Area of Public Hospital Reform in Nankai University
Study on rational drug use and pharmacy service model in Chongqing Medical University and China Pharmaceutical University
Cypress Blue Comments: Rational use of drugs, especially the rational use of drugs at the grassroots level, is the focus of future regulations.
5. Grab imitation, rare diseases and Chinese herbal medicines
China Pharmaceutical University International Drug Imitation Policy and Practical Case Study
Beijing Union Medical College Hospital China's rare disease and drug database establishment research
Standardization of the Selection and Analysis of Traditional Chinese Herbal Pieces in Nanjing University of Traditional Chinese Medicine
Cypress Blue comment: Grab imitation is a common policy adopted by developing countries to solve the high price problem of life-saving drugs. There are many cases of imitation imitation in India and Pakistan. The only time China announced that it intends to imitation is the WHO announced the global pandemic of bird flu. However, since the "global pandemic" was confirmed to be a lie soon, China's imitation plan was not implemented. The study of rare diseases can alleviate the burden on patients and is good news for the people.
The study of traditional Chinese medicine decoction pieces is worth noting. The consumption of traditional Chinese medicine decoction pieces in hospitals, especially in Chinese medicine hospitals, is not small. In the case of not occupying the proportion of medicines, etc., there is a good interest. There are also Chinese medicine decoction pieces in the basic medicines. For the selection and regulation of decoction pieces, it should be right. The industry has established standards to help the consumer tablets buy quality.